FDA grants approval for Veklury use in Covid-19 patients with severe renal impairment

FDA grants approval for Veklury use in Covid-19 patients with severe renal impairment

Submitted by admin on July 17, 2023 - 8:36am
Source: 
Pharmaceutical Business Review
News Tags: 
Gilead Sciences
COVID-19
FDA
Veklury
remdesivir
Headline: 
FDA grants approval for Veklury use in Covid-19 patients with severe renal impairment
snippet: 

The US Food and Drug Administration (FDA) has granted clearance to Gilead Sciences’ supplemental new drug application (sNDA) of Veklury (remdesivir) for use in Covid-19 patients.

Do Not Allow Advertisers to Use My Personal information